Nora A. Liguori-Fernandez
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Journal: Clinical neuropharmacology
Published: July 15, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Journal: Journal of the neurological sciences
Published: May 04, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Journal: Multiple sclerosis and related disorders
Published: February 26, 2024
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 22, 2024
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 06, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 05, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 27, 2022
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 09, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Journal: Multiple sclerosis and related disorders
Published: May 26, 2022
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 24, 2022
Acute disseminated encephalomyelitis following vaccination against SARS-CoV-2: A case report.
Journal: Brain, behavior, & immunity - health
Published: September 17, 2021
Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability.
Journal: Multiple sclerosis and related disorders
Published: August 18, 2021
Last Updated: 09/26/2026